Updated July 29, 2026

Lantus Cost Without Insurance: Cash Price, Sanofi Savings & Alternatives

$276–$350
Cash Price / Vial
$35
Sanofi Valyou Price
$0
Patient Assistance
400%
FPL Income Limit
Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr. Megan Harris, MD Medically Reviewed by Dr. Megan Harris, MD
Why trust this guide: Pricing was cross-checked against GoodRx, SingleCare, and Drugs.com pharmacy-pricing pages, Sanofi's own Insulins Valyou and Patient Connection program pages, and Medicare.gov guidance, current as of July 29, 2026. Refill Relay is not paid by Sanofi, Eli Lilly, or any company named in this guide.
Quick Answer

Without insurance, a single 10 mL vial of Lantus costs roughly $276 to $350 in cash at most US retail pharmacies in 2026, and a box of 5 SoloStar pens usually runs $350 to $450. That's the sticker price. You almost never have to pay it. Sanofi's own Insulins Valyou Savings Program lets any uninsured patient buy a 30-day supply of Lantus for $35 cash, no income check required. If you're uninsured and your household income is at or below 400% of the federal poverty level, Sanofi's Patient Connection program provides Lantus completely free. And if Lantus itself is hard to find or still too expensive, interchangeable biosimilars like Rezvoglar ($92–$150) or CalRx Insulin Glargine ($55 for a five-pack) work the same way and cost noticeably less.

The short version: nobody without insurance should be paying full cash price for Lantus in 2026. The rest of this guide shows exactly which program fits your situation and how to enroll.

$276–$350
Cash price,
10 mL vial
$35
Insulins Valyou
cash price
$0
Patient Connection
(income-qualified)
$55
CalRx alternative,
5-pack of pens

Key Takeaways

  • Lantus's real cash price is $276–$350 per vial at most pharmacies without any coupon or program — but almost nobody should actually pay that.
  • Sanofi's Insulins Valyou Savings Program caps the cash price at $35 for a 30-day supply, with no income requirement, for any uninsured patient.
  • Sanofi's Patient Connection program provides Lantus for free to uninsured patients at or below 400% of the federal poverty level.
  • Rezvoglar and CalRx Insulin Glargine are FDA-interchangeable with Lantus and cost less — $92–$150 and $55 respectively — meaning a pharmacist can typically substitute either without a new prescription.
  • Discount cards like GoodRx sometimes beat retail price but rarely beat Sanofi's own $35 program — compare both before you fill.
  • Sanofi cut Lantus's list price 78% effective 2024, but that discount mainly benefits insurers and PBMs, not the cash price an uninsured patient sees at the counter.

Searching "Lantus cost without insurance" usually turns up two very different numbers — a scary sticker price near $300, and a suspiciously simple "$35" figure that doesn't explain where it comes from. Both are real. The difference is entirely about which door you walk through at the pharmacy. This guide breaks down exactly what Lantus costs in cash, which Sanofi program actually applies to your situation, and what to do if Lantus isn't the right fit for your budget at all.

1. What Lantus Actually Costs in Cash

"Cash price" means what you'd pay at the pharmacy counter with no insurance, no coupon, and no manufacturer program applied. It's the number most people see first, and it's almost always the worst price available.

Lantus cash price by form, 2026
FormTypical cash price rangeNotes
10 mL vial$276–$350Most common form for syringe users
SoloStar pen, 5-pack (15 mL)$350–$450Pre-filled disposable pens
Per-unit cost (vial)~$0.28–$0.35/unitBased on 1,000 units per vial

Prices vary by pharmacy chain, region, and even day to day, so treat this as a planning range rather than an exact quote — always confirm with your specific pharmacy before assuming a price.

2. Why Lantus Is Priced This Way

Sanofi cut Lantus's list price by 78% effective 2024, which sounds like it should make the cash price much lower. It mostly doesn't, and here's why: that list-price cut primarily affects the net price insurers and pharmacy benefit managers pay after rebates, not the retail cash price posted at an uninsured patient's pharmacy counter. Many retail pharmacies still price cash-pay prescriptions off older list-price benchmarks or wholesale acquisition cost, which is why the sticker price can look disconnected from the "list price cut" headlines.

The practical takeaway: don't wait for the cash price to drop on its own. The $35 Sanofi savings program already reflects the intended affordable price — you just have to actively enroll in it rather than assume it happens automatically at checkout.

3. Sanofi's $35 Insulins Valyou Savings Program

This is the single most useful thing on this page for most uninsured Lantus patients. The Insulins Valyou Savings Program lets any uninsured or cash-pay patient buy up to a 30-day supply of Lantus (and other Sanofi insulins) for $35, with no income documentation required.

  • Who it's for: Uninsured patients, or patients who prefer to pay cash instead of running the prescription through insurance.
  • What you need: A valid Lantus prescription. No proof of income, no application approval wait.
  • How to enroll: Register at Sanofi's Insulins Valyou website or call 1-800-633-1610, then bring the printed or digital card to your pharmacy.
  • Limits: Caps apply per 30-day supply; check the current program terms for exact monthly quantity limits.

This is not the same as insurance. Insulins Valyou is a cash-pay discount, not a health plan — you're still buying the medication outright, just at a much lower price than the unsubsidized cash price.

4. Free Lantus: Sanofi Patient Connection

If $35 a month still isn't affordable, Sanofi's Patient Connection program provides Lantus completely free to uninsured patients who meet income requirements.

  • Income limit: Household income at or below 400% of the federal poverty level.
  • Insurance status: Must be uninsured — patients with any insurance, including Medicaid, generally don't qualify for this specific program.
  • Application: Requires proof of income, proof of no insurance coverage, and a section completed and signed by your prescriber.
  • Contact: Search "Sanofi Patient Connection" or call 1-800-633-1610 to start an application.

This is genuinely a separate program from Insulins Valyou, and mixing the two up is the most common mistake patients make (more on that below).

5. Eligibility Comparison

Who qualifies for each Lantus pricing path
ProgramInsurance status requiredIncome documentation
Cash price (no program)AnyNone
Insulins Valyou Savings ProgramUninsured or cash-payNone
Insulins Copay Savings ProgramCommercial insurance requiredNone
Sanofi Patient Connection (PAP)Must be uninsuredRequired, ≤400% FPL
Rezvoglar (Lilly, interchangeable)AnyNone for cash price; income-based for Lilly Cares PAP
CalRx Insulin Glargine (interchangeable)Any, insured or notNone

6. Income Limit Comparison

Where the 400% FPL cutoff falls, 2026 guidelines
Household size100% FPL (annual)400% FPL cutoff (annual)
1 person~$15,650~$62,600
2 people~$21,150~$84,600
3 people~$26,650~$106,600
4 people~$32,150~$128,600

These figures update annually with federal poverty guidelines, so treat them as directional — confirm the exact current-year numbers on Sanofi's Patient Connection application page before assuming you do or don't qualify.

7. Cheaper Alternatives to Lantus

If Lantus itself is hard to find, too expensive even with Valyou, or you simply want to compare options, these are the interchangeable and near-equivalent products worth asking your prescriber or pharmacist about.

Lantus alternatives, cash price and interchangeability
ProductManufacturerInterchangeable with Lantus?Typical cash price
RezvoglarEli LillyYes — FDA-interchangeable$92–$150 (5-pen carton)
CalRx Insulin GlargineCivica / Biocon (state-sponsored)Yes — FDA-interchangeable$55 flat (5-pack of pens)
BasaglarEli LillySimilar, but not designated interchangeable$300–$355 (5-pen carton)
ToujeoSanofiNo — different concentration (U-300)$171–$300 (3-pack pen)
SemgleeViatrisDiscontinued December 31, 2025N/A

Why "interchangeable" matters: an FDA-interchangeable biosimilar, like Rezvoglar or CalRx Insulin Glargine, can be substituted for Lantus by a pharmacist without contacting your prescriber first — similar to how a generic pill gets swapped for a brand-name one. That makes switching considerably faster than asking for an entirely new prescription.

8. What Else These Programs Cover

Sanofi programs beyond Lantus
ProgramAlso covers
Insulins Valyou Savings ProgramToujeo, Admelog, Apidra, Merilog
Insulins Copay Savings ProgramToujeo, Admelog, Apidra, Merilog (commercially insured)
Sanofi Patient ConnectionToujeo, Admelog, Apidra (income-qualified, uninsured)

If you're on more than one Sanofi insulin, it's worth checking whether one enrollment covers your full regimen rather than applying separately for each product.

9. Do Discount Cards Beat Sanofi's Own Price?

Sometimes, but not usually for Lantus specifically. Discount cards like GoodRx or Inside Rx negotiate pharmacy-specific rates that can occasionally undercut the retail cash price, but they rarely beat Sanofi's own $35 Insulins Valyou price, since that's already a manufacturer-subsidized rate rather than a pharmacy discount. The practical approach: check your specific pharmacy's GoodRx price and compare it side-by-side with the $35 Valyou price before filling — in most zip codes, Valyou wins, but it costs nothing to check both.

10. Step-by-Step: Getting the Lowest Price

1

Check your insurance status first

If you have any commercial insurance, ask about Sanofi's Insulins Copay Savings Program before assuming you need a cash-pay path.

2

If uninsured, enroll in Insulins Valyou first

This gets you to $35 immediately with no waiting period, while you figure out if you qualify for anything better.

3

Check your income against the 400% FPL threshold

If you're under that line, apply for Sanofi Patient Connection for free medication going forward — it takes longer to process than Valyou, so keep using Valyou in the meantime.

4

Compare against interchangeable alternatives

Price out Rezvoglar and CalRx Insulin Glargine at your pharmacy — if either is cheaper or more available, ask your pharmacist about substituting.

5

Never ration your dose to make it last

If cost is forcing you to skip doses, contact your prescriber or a program like patient assistance immediately — insulin dosing errors carry serious health risks.

11. Approval and Processing Timelines

How long each path takes
PathTypical timeline
Insulins Valyou enrollmentSame day — no approval wait
Insulins Copay Savings ProgramSame day, once commercial insurance is confirmed
Sanofi Patient Connection applicationTypically 1–3 weeks, depending on documentation completeness
Switching to an interchangeable alternativeSame day at the pharmacy counter, no new prescription needed

12. Renewing Your Enrollment

  • Insulins Valyou generally needs to stay active per fill — confirm whether your card requires periodic re-verification.
  • Sanofi Patient Connection typically requires annual re-application with updated income documentation.
  • If your insurance status changes (you gain or lose coverage), re-check which program you actually qualify for — moving from uninsured to insured usually shifts you from Patient Connection to the Copay Savings Program.
  • If you switch to an interchangeable alternative, confirm your new product's savings program separately; enrollments don't automatically transfer between manufacturers.

13. Common Mistakes to Avoid

Mistakes patients make

  • Paying full cash price without checking Insulins Valyou first
  • Assuming Patient Connection and Insulins Valyou are the same program
  • Applying for the free PAP while still having active insurance
  • Not comparing GoodRx against Sanofi's own $35 price
  • Rationing doses instead of contacting a program or prescriber

What works well

  • Enrolling in Valyou before your first uninsured fill, not after a high bill
  • Checking income against the 400% FPL threshold every year
  • Asking the pharmacist directly about interchangeable alternatives
  • Keeping proof-of-income documents ready before applying for Patient Connection
  • Re-checking eligibility whenever insurance status changes

14. Pros and Cons of Each Option

Insulins Valyou ($35)

  • No income check, no waiting period
  • Works the same day at the pharmacy
  • No ongoing paperwork once enrolled

Insulins Valyou ($35)

  • Still a real monthly cost, not free
  • Only usable if you're uninsured or paying cash
  • Quantity limits apply per 30-day supply

Patient Connection (free)

  • $0 cost for qualifying patients
  • Covers a full supply, not just a discount

Patient Connection (free)

  • Requires income documentation and annual renewal
  • Takes longer to process than Valyou
  • Not available if you have any insurance

15. Decision Tree: Which Path Fits You?

Do you have commercial insurance that covers Lantus?
Yes — use Sanofi's Insulins Copay Savings Program for your copay.
No / uninsured — continue below.
Is your household income at or below 400% of the federal poverty level?
Yes — apply for Sanofi Patient Connection for free Lantus, and use Valyou in the meantime.
No — continue below.
Result: Enroll in Insulins Valyou for $35, or compare Rezvoglar / CalRx

Either gets you to a low, predictable monthly cost without income documentation.

Related: Lantus Shortage 2026: Pharmacy Availability & Alternatives

If your pharmacy is out of Lantus specifically, this guide covers what's actually driving that and what to fill instead.

Frequently Asked Questions

A single 10 mL vial of Lantus typically costs between $276 and $350 in cash at US retail pharmacies in 2026. A box of 5 SoloStar pens usually costs more, often $350 to $450, depending on the pharmacy. These are list-level cash prices before any coupon or savings program is applied.

Yes, through Sanofi's Insulins Valyou Savings Program, uninsured patients can buy up to a 30-day supply of Lantus for $35 in cash, regardless of income. This is separate from Sanofi's free patient assistance program and requires enrolling in Valyou through Sanofi's website or by phone before filling the prescription.

Uninsured patients with household income at or below 400% of the federal poverty level may qualify for free Lantus through the Sanofi Patient Connection patient assistance program. The application requires proof of income, proof of no insurance coverage, and a section completed by your prescriber.

Rezvoglar, an FDA-interchangeable biosimilar to Lantus made by Eli Lilly, typically costs $92 to $150 in cash and is eligible for Lilly's own $35 savings program. California's CalRx Insulin Glargine, also interchangeable with Lantus, sells for a flat $55 for a five-pack of pens regardless of insurance status. Both can usually be substituted for Lantus by a pharmacist without a new prescription.

Discount cards like GoodRx or Inside Rx can lower Lantus's cash price somewhat below the sticker price at some pharmacies, but they typically don't beat Sanofi's own $35 Insulins Valyou Savings Program. Compare both before filling, since the better deal depends on your specific pharmacy and zip code.

Lantus's cash price reflects its wholesale list price, which is set by Sanofi and negotiated separately with insurers and pharmacy benefit managers. Sanofi cut Lantus's list price by 78% effective 2024, but the cash price at the pharmacy counter for an uninsured patient without a savings card still reflects the pre-discount pricing structure used by most retail pharmacies, not the lower net price insurers pay.

Yes. Under the Inflation Reduction Act, Medicare Part D and Part B plans cap covered insulin, including Lantus, at $35 per month automatically, with no deductible applying. This is separate from Sanofi's own savings programs, which are designed for commercial or uninsured patients rather than Medicare beneficiaries. See Medicare.gov or CMS guidance for plan-specific formulary details.

Helpful Outside Resources

Disclaimer: This guide is for general educational purposes and reflects publicly available Lantus pricing and program information as of July 29, 2026. It does not constitute medical advice. Prices, income limits, and program terms can change — confirm current details directly with Sanofi, your pharmacy, or Medicare, and never change your insulin product, dose, or schedule without first talking to your prescriber.

Evan Brown
About the Author
Evan Brown — Prescription Savings Researcher

Evan Brown specializes in translating complex prescription pricing and patient assistance programs into clear, actionable guidance for patients navigating medication costs.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD

Dr. Megan Harris, MD reviews health content for accuracy, checking pricing program details and pharmacy network claims against current sources.

View Full Profile →

Contact Refill Relay